For the Inventor, By the Inventor

Enter inventor name

Marc Alizon

USPTO Granted Patents = 62

CIPO Patents = 3

EPO Patents = 2

Average Co-Inventor Count = 5.7

ph-index = 10

Forward Citations = 353(Granted Patents)

Forward Citations (Not Self Cited) = 299(Dec 10, 2025)

Inventors with similar research interests:

Location History:

75005 Paris, FR (2001)
Paris, FR (1991 - 2013)

Company Filing History:

Institut Pasteur

Centre National De La Recherche Scientifique

Institut Pasteur and Centre National De La Recherche Scientifique

4. 2 out of 3,566

The United States of America, as Represented by the Secretary, Department of Health and Human Services

5. 6 out of 832,966

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2013

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Human Immunodeficiency Virus Type 1

Human Immunodeficiency Virus Type 2

Nucleic Acid Probes

Cloned DNA Sequences

Diagnostic Assays

Peptide Vaccines

Retrovirus Detection

Antibody Detection

Viral Extract Preparation

Genomic RNA

Lymphadenopathy Associated Virus

HIV Antigens

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8507196 - Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1 (2013-08-13),

2. 8329396 - Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV) (2012-12-11),

3. 7767800 - [object Object] (2010-08-03),

4. 7626013 - HIV-1 DNA fragments that hybridize to genomic HIV-1DNA (2009-12-01),

5. 7585619 - Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity (2009-09-08),

6. 7351412 - Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA (2008-04-01),

7. 7341731 - HIV-2 antigen compositions (2008-03-11),

8. 7232654 - DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) (2007-06-19),

9. 7217508 - Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) (2007-05-15),

10. 7119181 - DNA sequences and peptides of human immunodeficiency virus (HIV-1) (2006-10-10),

11. 7115363 - Retrovirus capable of causing AIDS, means and methods for detecting it in vitro (2006-10-03),

12. 7045130 - Antibodies against antigens of human immunodeficiency virus (HIV-1) (2006-05-16),

13. 7029679 - Variant of LAV viruses (2006-04-18),

14. 6979535 - Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays (2005-12-27),

15. 6951648 - Variant of LAV viruses (2005-10-04),

Title: Marc Alizon - Innovative Inventor from Paris

Introduction: Marc Alizon is a renowned inventor based in Paris, France, known for his groundbreaking contributions to various industries.

Latest Patents: Marc Alizon holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Marc Alizon has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Marc Alizon has collaborated with leading research institutions, universities, and multinational companies, fostering a culture of innovation and knowledge-sharing.

Conclusion: Marc Alizon's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…